Publication | Closed Access

Design of compounds having enhanced tumour uptake, using serum albumin as a carrier—part II. In vivo studies

Carrier—part IiDrug TargetingSerum AlbuminMedicineTheranosticsDrug Delivery SystemsTumour UptakeTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyDrug Discovery